Skip to main content
. 2015 Oct 16;21(6):10.18553/jmcp.2015.21.6.486. doi: 10.18553/jmcp.2015.21.6.486

TABLE 2.

Drug Classes Used in This Study

Drug Class Medication
Long-acting stimulants Methylphenidate (Ritalin LA, Metadate CD, Concerta, Daytrana)
Dexmethylphenidate (Focalin XR)
Mixed amphetamine salts (Adderall XR, Amphetamine-Dextroamphetamine cap SR 24HR)
Pemoline (generic, Cylert)
Lisdexamfetamine dimesylate (Vyvanse)
Atypical antipsychotics Ziprasidone, paliperidone, risperidone, olanzapine, aripiprazole, clozapine, quetiapine
Nonstimulants Atomoxetine
Alpha 2-agonists Clonidine, guanfacine
Antidepressants Bupropion, tricyclic antidepressants (e.g., desipramine)
Selective serotonin reuptake inhibitors (e.g., fluvoxamine)
Selective norepinephrine reuptake inhibitors (e.g., venlafaxine)
Others (e.g., isocarboxazid)
Mood stabilizers Lithium, anticonvulsants (e.g., gabapentine)
Sedatives/hypnotics/anxiolytics Anxiolytics (e.g., chloral hydrate), beta blockers (e.g., acebutolol), benzodiazepines (e.g., diazepam), antihistamines (e.g., cetirizine)
Miscellaneous Anticholinergics (e.g., benztropine), antiparkinsonian agents (e.g., levodopa)